欧洲精品一区二区三区_欧美性性性性_国产一区二区免费在线播放_日日噜噜噜噜人人爽日本精品_无套中出丰满人妻无码_国产偷窥熟女精品视频大全

美國 NeuroSigma  
位于加利福尼亞州洛杉磯市的NeuroSigma公司的新產品——Monarch外部三叉神經激發(eTNS)系統已經通過歐盟批準。在產品發布會上，該公司把它被定義為9歲及以上癲癇和抑郁癥患者的輔助治療系統。

NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma has a growing pipeline of treatments targeting epilepsy, depression, post-traumatic stress disorder (PTSD), obesity, among others and is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I and Phase II clinical trials. NeuroSigma is utilizing two distinct therapy platforms:

Deep Brain Stimulation (DBS) - Pioneered in France for the treatment of essential tremor and Parkinson’s disease. New therapies in development by NeuroSigma.

Trigeminal Nerve Stimulation (TNS) - A proprietary therapy developed at the University of California, Los Angeles and exclusively licensed to NeuroSigma.

CAUTION: The TNS and DBS therapies being developed by NeuroSigma are investigational therapies and limited by United States law for investigational use.